-
Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects.
Pereira S, Ganapathy R, Syngelaki A, Maiz N, Nicolaides KH.
Obstet Gynecol 2011;117:1384-91. -
Screening for fetal aneuploidies at 11 to 13 weeks.
Nicolaides KH.
Prenat Diagn 2011;31:7-15. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Liver volume in trisomy 21 and euploid fetuses at 11 to 13 weeks.
Gielchinsky Y, Zvanca M, Minekawa R, Persico N, Nicolaides KH.
Prenat Diagn 2011;31:28-32. -
Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6-week scan: association with chromosomal defects and reproducibility of the method.
Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:609-12. -
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:151-5.